JODI PALMER: Open Payments
NPI 1578942165 · ANTHEM, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 35 payments from 14 companies in 2025. Trend: 2023 $694 · 2024 $635 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 5 | $123 |
| ABBVIE INC. | 5 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Amgen Inc. | 3 | $51 |
| PFIZER INC. | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| TOLMAR, INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: The Cologuard Plus Collection Kit, CAPLYTA, TRELEGY ELLIPTA, UBRELVY, RECORLEV, QULIPTA, OTEZLA, JATENZO.
Industry payments across AZ — which companies pay providers there.
